The “AI Drug Discovery and Design Global Market Insights 2021, Analysis and Forecast to 2026, by Market Participants, Regions, Technology, Application” rp;'[-0/=eport has been added to ResearchAndMarkets.com’s offering.
This report describes the global market size of AI Drug Discovery and Design from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report includes global key players of AI Drug Discovery and Design as well as some small players.
Companies Covered:
- Relay Therapeutics
- AbCellera
- Schrodinger
- Recursion Pharmaceuticals
- PathAI
- Insitro
- Valo Health
- Cellarity
- XtalPi
- BenevolentAI
- Datavant
- Atomwise
- Exscientia Ltd
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment:
- Precision Target
- Precision Design
- Precision Experiment
- Precision Medicine
Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
